TY - JOUR
T1 - Preferential selection and transfer of euploid noncarrier embryos in preimplantation genetic diagnosis cycles for reciprocal translocations
AU - Wang, Li
AU - Shen, Jiandong
AU - Cram, David S.
AU - Ma, Minyue
AU - Wang, Hui
AU - Zhang, Wenke
AU - Fan, Junmei
AU - Gao, Zhiying
AU - Zhang, Liwen
AU - Li, Zhifeng
AU - Xu, Mengnan
AU - Leigh, Don A.
AU - Trounson, Alan O.
AU - Liu, Jiayin
AU - Yao, Yuanqing
PY - 2017/10
Y1 - 2017/10
N2 - Objective: To develop and validate a new strategy to distinguish between balanced/euploid carrier and noncarrier embryos in preimplantation genetic diagnosis (PGD) cycles for reciprocal translocations and to successfully achieve a live birth after selective transfer of a noncarrier embryo. Design: Retrospective and prospective study. Setting: In vitro fertilization (IVF) units. Patient(s): Eleven patients undergoing mate pair sequencing for identification of translocation breakpoints, followed by clinical PGD cycles. Intervention(s): Embryo biopsy with 24-chromosome testing to determine carrier status of balanced/euploid embryos. Main Outcome Measure(s): Definition of translocation breakpoints and polymerase chain reaction (PCR) diagnostic primers, correct diagnosis of euploid embryos for carrier status, and a live birth with a normal karyotype after transfer of a noncarrier embryo. Result(s): In 9 of 11 patients (82%), translocation breakpoints were successfully identified. In four patients with a term PGD pregnancy established with a balanced/euploid embryo of unknown carrier status, the correct carrier status was retrospectively determined, matching with the cytogenetic karyotype of the resulting newborns. In a prospective PGD cycle undertaken by a patient with a 46,XY,t(7;14)(q22;q24.3) translocation, the four balanced/euploid embryos identified comprised three carriers and one noncarrier. Transfer of the noncarrier embryo resulted in birth of a healthy girl who was subsequently confirmed with a normal 46,XX karyotype. Conclusion(s): The combination of mate pair sequencing and PCR breakpoint analysis of balanced reciprocal translocation derivatives is a novel, reliable, and accurate strategy for distinguishing between carrier and noncarrier balanced/euploid embryos. The method has potential application in clinical PGD cycles for patients with reciprocal translocations or other structural rearrangements.
AB - Objective: To develop and validate a new strategy to distinguish between balanced/euploid carrier and noncarrier embryos in preimplantation genetic diagnosis (PGD) cycles for reciprocal translocations and to successfully achieve a live birth after selective transfer of a noncarrier embryo. Design: Retrospective and prospective study. Setting: In vitro fertilization (IVF) units. Patient(s): Eleven patients undergoing mate pair sequencing for identification of translocation breakpoints, followed by clinical PGD cycles. Intervention(s): Embryo biopsy with 24-chromosome testing to determine carrier status of balanced/euploid embryos. Main Outcome Measure(s): Definition of translocation breakpoints and polymerase chain reaction (PCR) diagnostic primers, correct diagnosis of euploid embryos for carrier status, and a live birth with a normal karyotype after transfer of a noncarrier embryo. Result(s): In 9 of 11 patients (82%), translocation breakpoints were successfully identified. In four patients with a term PGD pregnancy established with a balanced/euploid embryo of unknown carrier status, the correct carrier status was retrospectively determined, matching with the cytogenetic karyotype of the resulting newborns. In a prospective PGD cycle undertaken by a patient with a 46,XY,t(7;14)(q22;q24.3) translocation, the four balanced/euploid embryos identified comprised three carriers and one noncarrier. Transfer of the noncarrier embryo resulted in birth of a healthy girl who was subsequently confirmed with a normal 46,XX karyotype. Conclusion(s): The combination of mate pair sequencing and PCR breakpoint analysis of balanced reciprocal translocation derivatives is a novel, reliable, and accurate strategy for distinguishing between carrier and noncarrier balanced/euploid embryos. The method has potential application in clinical PGD cycles for patients with reciprocal translocations or other structural rearrangements.
KW - Balanced/euploid embryos
KW - Mate pair sequencing
KW - Preimplantation genetic diagnosis
KW - Reciprocal translocations
KW - Translocation breakpoints
UR - http://www.scopus.com/inward/record.url?scp=85028453300&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2017.07.010
DO - 10.1016/j.fertnstert.2017.07.010
M3 - Article
AN - SCOPUS:85028453300
VL - 108
SP - 620
EP - 627
JO - Fertility and Sterility
JF - Fertility and Sterility
SN - 0015-0282
IS - 4
ER -